Cargando…

Factors associated with SARS-CoV-2 and community-onset invasive Staphylococcus aureus coinfection, 2020

Background: Previous analyses describing the relationship between SARS-CoV-2 infection and Staphylococcus aureus have focused on hospital-onset S. aureus infections occurring during COVID-19 hospitalizations. Because most invasive S. aureus (iSA) infections are community-onset (CO), we characterized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackson, Kelly, Resler, Sydney, Nadle, Joelle, Petit, Susan, Ray, Susan, Harrison, Lee, Lynfield, Ruth, Como-Sabetti, Kathryn, Bernu, Carmen, Dumyati, Ghinwa, Tracy, Marissa, Schaffner, William, Biggs, Holly, See, Isaac
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Mrsa/Vre
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594277/ http://dx.doi.org/10.1017/ash.2023.342

Ejemplares similares

Methicillin-resistant Staphylococcus aureus mupirocin resistance rates in a large healthcare system
por: Sampson, Mindy, et al.
Publicado: (2023)

Targeted Staphylococcus aureus decolonization in acute inpatient and intensive care settings of an academic medical center
por: DiTullio, David, et al.
Publicado: (2022)

Impact of discontinuation of contact precautions on surveillance- and whole-genome sequencing-defined MRSA infections
por: Karunakaran, Sharon, et al.
Publicado: (2023)

Hospital Onset Vancomycin-Resistant Enterococci Infections in a Northern California Tertiary-Care Center From 2019 to 2020
por: Rasmussen, Stephanie, et al.
Publicado: (2021)

Discontinuation of Contact Precautions in Patients with Nosocomial MRSA and VRE Infections During the COVID-19 Pandemic
por: Hudson, Marisa, et al.
Publicado: (2021)

740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020
por: Jackson, Kelly A, et al.
Publicado: (2023)

Increases in methicillin-sensitive Staphylococcus aureus bloodstream infection incidence, 2016–2019
por: Jackson, Kelly, et al.
Publicado: (2022)

2456. Methicillin-Resistant Staphylococcus aureus Bacteremia 30-Day Mortality During 2020 Compared to 2016-2019: Assessing the Impact of COVID-19
por: Biggs, Holly, et al.
Publicado: (2023)

469. Contributions of Infections among Persons Who Inject Drugs to the Changing Incidence of Healthcare-Associated, Community-Onset Methicillin-Resistant Staphylococcus aureus Infections, 2009–2017
por: Jackson, Kelly A, et al.
Publicado: (2019)

1059. Staphylococcus aureus Bacteremia Treatment: Results From Pilot Surveillance in Four US States
por: Kabbani, Sarah, et al.
Publicado: (2018)

1230. Epidemiology and Risk Factors for Recurrent Invasive Methicillin-Resistant Staphylococcus aureus Infection: nine US States, 2006–2013
por: Kracalik, Ian, et al.
Publicado: (2018)

1443. Characteristics of nursing homes with higher rates of invasive methicillin-resistant Staphylococcus aureus infections
por: See, Isaac, et al.
Publicado: (2023)

Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016
por: Jackson, Kelly A., et al.
Publicado: (2018)

Vital Signs: Health Disparities in Hemodialysis-Associated Staphylococcus aureus Bloodstream Infections — United States, 2017–2020
por: Rha, Brian, et al.
Publicado: (2023)

887 Opportunities to Improve Completeness of MRSA Bloodstream Infection Reporting From Outpatient Hemodialysis Facilities to the National Healthcare Safety Network
por: Nguyen, Duc, et al.
Publicado: (2014)

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States
por: Kourtis, Athena P., et al.
Publicado: (2019)

Burdens of Invasive Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Disease, Minnesota, USA
por: Koeck, Mackenzie, et al.
Publicado: (2019)

1211. Increasing Incidence of Invasive Methicillin-Resistant and Methicillin-Sensitive S. aureus Infections Among Persons Who Inject Drugs, 2014–2017
por: Felsen, Christina B, et al.
Publicado: (2018)

Methicillin-Resistant Staphylococcus aureus at Canoe Camp
por: Como-Sabetti, Kathryn, et al.
Publicado: (2006)

137 Developing an Approach to Evaluating the Quality of Antibiotic Prescribing in Hospitalized Patients with Community-Acquired Pneumonia (CAP) and Non-catheter Associated Urinary Tract Infection (UTI)
por: Fagan, Ryan, et al.
Publicado: (2014)

Reduction in the Prevalence of Healthcare-Associated Infections in U.S. Acute Care Hospitals, 2015 vs 2011
por: Magill, Shelley S, et al.
Publicado: (2017)

Community-associated Methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003
por: Buck, Jessica M., et al.
Publicado: (2005)

Community-associated Methicillin-resistant Staphylococcus aureus and Healthcare Risk Factors
por: Klevens, R. Monina, et al.
Publicado: (2006)

527. Lower Risk of ICU Admission with Remdesivir in Patients Hospitalized with COVID-19 Pneumonia
por: Lim, Sarah, et al.
Publicado: (2021)

715. Increase in Reported Respiratory Syncytial Virus Cases Among Adults in the Minneapolis-St. Paul Metropolitan Area, 2014–2018
por: Como-Sabetti, Kathryn, et al.
Publicado: (2018)

1925. Prevalence of SARS-CoV-2 Infection in Immunocompromised Patients Following Receipt of Tixagevimab/Cilgavimab
por: Lim, Sarah, et al.
Publicado: (2022)

685. Correlation Between Hospitalized Influenza and Group A Streptococcus Infections in Minnesota, 2010–2016
por: Arogbokun, Olufunmilayo, et al.
Publicado: (2018)

Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States
por: Magill, Shelley S., et al.
Publicado: (2015)

1009. Measuring the quality of fluoroquinolone prescribing in hospitals: results from the Emerging Infections Program Hospital Prevalence Survey Antimicrobial Quality Assessment
por: Magill, Shelley S, et al.
Publicado: (2019)

Clinician Knowledge and Beliefs after Statewide Program to Promote Appropriate Antimicrobial Drug Use
por: Kiang, Karen M., et al.
Publicado: (2005)

787 Respiratory Pathogen Detection in Cases of Severe Acute Respiratory Illness (SARI) Among Hospitalized Patients at Two Metro-Area Hospitals, Minnesota, 2013-2014
por: Friedlander, Hannah, et al.
Publicado: (2014)

468. Epidemiologic Features of Invasive Methicillin-Resistant Staphylococcus aureus and Group A Streptococcus Infections among Adults Who Inject Drugs in the San Francisco Bay Area, 2008–2017
por: Nadle, Joelle, et al.
Publicado: (2019)

186. Characteristics of COVID-19 Vaccine Breakthrough Cases in Minnesota, 2021
por: Meyer, Stephanie, et al.
Publicado: (2021)

Comparison of Respiratory Pathogen Detections from Routine Hospital Testing and Expanded Systematic Testing from the Minnesota Severe Acute Respiratory Illness Surveillance Program, 2015–2016
por: Steffens, Andrea, et al.
Publicado: (2017)

ICD-9 code reporting among patients from the Minnesota SARI surveillance program
por: Steffens, Andrea, et al.
Publicado: (2017)

Epidemiology of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacterales in US children, 2016–2020
por: Grome, Heather, et al.
Publicado: (2023)

Hospital-Nursing Home Transfer Patterns and Influence on Nursing Home Clostridium difficile Infection Rates
por: Campbell, Lauren, et al.
Publicado: (2017)

1642 Identifying Targets for Prevention Through Clostridium difficile Population Surveillance
por: Dumyati, Ghinwa, et al.
Publicado: (2014)

Systematic review of antibiotic stewardship interventions for urinary tract infection management in the ambulatory setting
por: Munsiff, Sonal, et al.
Publicado: (2022)

1836. Characteristics of Nursing Homes Associated With Self-reported Implementation of Centers for Disease Control and Prevention (CDC) Core Elements of Antibiotic Stewardship
por: Thompson, Nicola D, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nm78k6me069r25g1q7udto5g3v